163 related articles for article (PubMed ID: 21502022)
1. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
Kulkarni AS; Gaja JB
PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
[TBL] [Abstract][Full Text] [Related]
2. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.
Javadzadeh Y; Shariati H; Movahhed-Danesh E; Nokhodchi A
Drug Dev Ind Pharm; 2009 Feb; 35(2):243-51. PubMed ID: 18785038
[TBL] [Abstract][Full Text] [Related]
3. In vitro release evaluation of hydrocortisone liquisolid tablets.
Spireas S; Sadu S; Grover R
J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
[TBL] [Abstract][Full Text] [Related]
4. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
5. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
6. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
Hentzschel CM; Sakmann A; Leopold CS
Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of griseofulvin release from liquisolid compacts.
Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
[TBL] [Abstract][Full Text] [Related]
8. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
[TBL] [Abstract][Full Text] [Related]
9. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
Spireas S; Wang T; Grover R
Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
[TBL] [Abstract][Full Text] [Related]
10. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
11. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
[TBL] [Abstract][Full Text] [Related]
12. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.
El-Hammadi M; Awad N
AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
[TBL] [Abstract][Full Text] [Related]
14. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
Kamble PR; Shaikh KS; Chaudhari PD
Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.
Prajapati ST; Bulchandani HH; Patel DM; Dumaniya SK; Patel CN
J Drug Deliv; 2013; 2013():870579. PubMed ID: 24232077
[TBL] [Abstract][Full Text] [Related]
16. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
17. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
18. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
[TBL] [Abstract][Full Text] [Related]
19. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
20. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
Patel DS; Pipaliya RM; Surti N
Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
